SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3061ANIK -15%, giving back 2/3 of gains since a report of good earnings on August 1.tnsaf-8/8/2013
3060HALO on P2 Cinryze halt. Looks like vphm is driving on without halo...consider fred hayes-8/1/2013
3059SQNM -29% on 2Q13 results.idos-7/25/2013
3058SRPT Unusual to see a stock grace the fireworks and the firesales boards on thetom pope-7/24/2013
3057[a day late] MACK -28% CAMBRIDGE, Mass., July 11, 2013 (GLOBE NEWSWIRE) --Merritnsaf-7/13/2013
3056Notes from ACHN’s CC: siliconinvestor.comDewDiligence_on_SI-7/1/2013
3055ACHN off as much as 25% AH, now about 20%. 4:07PM Achillion Pharma provides updIan@SI-7/1/2013
3054PPHM -23% on yet another bullshit PR that tried to hide the failure in first-linThe Dodgy Ticker-6/27/2013
3053RVXCF -93% (!) on clinical-trial failure.DewDiligence_on_SI-6/27/2013
3052PPHM -23% on yet another bullshit PR that tried to hide the failure in first-linDewDiligence_on_SI-6/27/2013
3051My take on the IDIX situation, FWIW: siliconinvestor.com siliconinvestor.comDewDiligence_on_SI-6/21/2013
3050Idenix (IDIX) off 27% for the day, as the FDA puts clinical hold on a their leadtuck-6/20/2013
3049dvax on need for more safety data (heplisav). But 30 percent seems overdone herfred hayes-6/10/2013
3048Rigel off 20% premarket to all time lows as Astra Zeneca bails on the partnershituck-6/4/2013
3047Synta (SNTA) off 32% on so-so data at ASCO. Cheers, Tucktuck-6/3/2013
3046Infinity (INFI) has had an incredible run(to ~$50!!) based on good if not abundtuck-6/3/2013
3045Born at the wrong time, into the wrong dogma. Small molecule companies have morscaram(o)uche-5/28/2013
3044GNVC bites the dust: GenVec Board Approves Liquidation, Dissolution Plan 9:00 sjemmeri-5/28/2013
3043XNPT -25% on MS drug resultsbiofisher-5/20/2013
3042another comment..... my basis is under $2, and way, way under if you count all tscaram(o)uche-5/16/2013
3041thanks Rickfred hayes-5/16/2013
3040And there's nothing I like as much as whiplash. Been a couple of years sincescaram(o)uche-5/16/2013
3039Merck can get this vaccine approved with a blindfold, if there are long-term surscaram(o)uche-5/16/2013
3038Seems way overdone. I know you're not supposed to pay attention to subgroup fred hayes-5/16/2013
303721% and falling. ONTYscaram(o)uche-5/16/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News